Inozyme Pharma Inc reports results for the quarter ended in June - Earnings Summary

Inozyme Pharma

11/08/2021 11:35

* Inozyme Pharma Inc  INZY.OQ  reported a quarterly adjusted
loss of 53 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 57 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Inozyme Pharma Inc's reported EPS for the quarter was a loss
of 53 cents​.
* The mean earnings estimate of analysts had risen by about 0.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Inozyme Pharma Inc shares had fallen by 6.2% this quarter and
lost 22.5% so far this year.
* The company reported a quarterly loss of $12.54 million.
* Wall Street's median 12-month price target for Inozyme Pharma
Inc is $37.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 10:35 a.m.  ​All
figures in US dollars unless otherwise stated